+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus



Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus



Biological and Pharmaceutical Bulletin 35(11): 2036-2042



The papain-like protease (PL(pro)), which controls replication of the severe acute respiratory syndrome coronavirus (SARS-CoV), has been identified as a potential drug target for the treatment of SARS. An intensive hunt for effective anti-SARS drugs has been undertaken by screening for natural product inhibitors that target SARS-CoV PL(pro). In this study, diarylheptanoids 1-9 were isolated from Alnus japonica, and the inhibitory activities of these compounds against PL(pro) were determined. Of the isolated diarylheptanoids, hirsutenone (2) showed the most potent PL(pro) inhibitory activity, with an inhibitory concentration (IC(50)) value of 4.1 µM. Structure-activity analysis showed that catechol and α,β-unsaturated carbonyl moiety in the molecule were the key requirement for SARS-CoV cysteine protease inhibition.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 052591522

Download citation: RISBibTeXText

PMID: 22971649


Related references

Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus. Biochemical Pharmacology 75(8): 1601-1609, 2008

The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme. Journal of Virology 79(24): 15199-15208, 2005

The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. Journal of Virology 79(24): 15189-15198, 2005

Deubiquitination, a new function of the severe acute respiratory syndrome coronavirus papain-like protease?. Journal of Virology 79(7): 4550-4551, 2005

Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme. Proceedings of the National Academy of Sciences of the United States of America 103(15): 5717-5722, 2006

Differential domain structure stability of the severe acute respiratory syndrome coronavirus papain-like protease. Archives of Biochemistry and Biophysics 520(2): 74-80, 2012

Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. Journal of Biological Chemistry 282(44): 32208-32221, 2007

Structural basis for catalysis and ubiquitin recognition by the severe acute respiratory syndrome coronavirus papain-like protease. Acta Crystallographica. Section D Biological Crystallography 70(Pt 2): 572-581, 2014

Correlation between TGF-β1 expression and proteomic profiling induced by severe acute respiratory syndrome coronavirus papain-like protease. Proteomics 12(21): 3193-3205, 2012

Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. Journal of Virology 78(24): 13600-13612, 2004

Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition. Biochemistry 44(30): 10349-10359, 2005

Thiopurine analogue inhibitors of severe acute respiratory syndrome-coronavirus papain-like protease, a deubiquitinating and deISGylating enzyme. Antiviral Chemistry and ChemoTherapy 19(4): 151-156, 2009

Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, protein-ligand X-ray structure and biological evaluation. Journal of Medicinal Chemistry 53(13): 4968-4979, 2010

Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors for the severe acute respiratory syndrome-coronavirus papain-like protease. Journal of Medicinal Chemistry 52(16): 5228-5240, 2009

Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus. Antiviral Research 115: 9, 2015